To evaluate microvascular complications in Diabetes Mellitus (DM) and to study correlation of Microvascular Complication with duration of diabetes, glycemic control and hypertension in a tertiary care centre. Though the study is not uncommon there are very few published reports on correlation of all three factors (together in the same study) with microvascular complications of diabetes mellitus.
Introduction
Diabetes Mellitus (DM) is a chronic disorder characterized by impaired metabolism of glucose and other energy yielding fuels as well as by the late development of vascular and neuropathic complications. Diabetes comprises of a group of disorders involving distinct pathogenic mechanisms, for which hyperglycemia is a common denominator. Both types of diabetes are preceded by a phase of abnormal glucose hemostasis as the pathogenic processes progress. Type I diabetes is the result of complete or near total insulin deficiency. Type II DM is a heterogeneous group of disorder characterized by variable degree of insulin resistance, impaired insulin secretion and increased glucose production. Diabetes is etiologically classified as Type I, Type II, other specific types as genetic defects, disease of exocrine pancreas, endocrinopathies, drug induced, infections, uncommon forms of immune-mediated diabetes and gestational diabetes.
Type I DM is the result of interactions of genetic environment and immunological factors that ultimately lead to the destruction of the pancreatic beta cells and insulin deficiency. Type II DM is characterized by insulin resistance, impaired insulin secretion and increased hepatic glucose production. Complication of diabetes are acute like diabetic ketoacidosis and hyperglycemic hyperosmolar state and chronic like microvascular complications-retinopathy, neuropathy and nephropathy and macrovascular complications. Diabetic Retinopathy may be the most common microvascular complication of diabetes and is responsible for 10,000 new cases of blindness every year in United States alone [1, 2] .
Materials and methods
This is a retrospective observational study done through 2007 to 2009 in a tertiary care general hospital and comprises a study group of 500 patients who were subjected to detailed history, physical investigations and laboratory investigations.
The diagnosis and classification of diabetes as Type I and Type II is based on ADA guidelines 2007. The patients' history, laboratory investigations and physical examination was obtained by retrospective chart review and medical record review. had duration of diabetes <5 years while 95/115 (83%) patients with no microvascular complications had HbA1c < 7.0%.
In our present study 85/210 (40%) patients with diabetic retinopathy had duration of diabetes 10-15 years while 115/210 (55%) had duration >15 years (Table 13 ). All 210 patients with diabetic retinopathy had HbA1c > 7.0% which implies poor glycemic control while 190/210 (90%) patients with diabetic retinopathy had hypertension. (Tables 14  and 15 ).
Diabetic Neuropathy was seen in 20/190 (10.5%) patients with duration of diabetes > 20 years while when duration of diabetes was physical examination had undergone detailed laboratory investigations in form of random blood sugar, fasting and postprandial blood sugar, HbA1c, s. creatinine, urine for protein and microalbuminuria, ultrasound for kidney size, fundus examination, vibration perception test, electromyography and nerve conduction velocity tests.
Results
In our study, Male to Female ratio was 1.08:1. Maximum incidence of diabetes was seen between 60-79 years in 240 (48%) patients. Mean age of the group was 55.02 years ( Table 1 ). 420 (84%) patients in the study had type II DM ( Table 2 ). 160 (32%) patients had DM for 11-15 years ( Table 3 ). In our study, microvascular complications were present in 385 (77%) patients ( Table 4 ). 95 (83%) patients of the 115 patients without microvascular complications of had HbA1c < 7.0 ( Table 5 ). 80 (70%) patients of the115 patients without microvascular complications had duration < 5 years (Table 6 ). 210 (42%) patients had Diabetic retinopathy and 140 (66.66%) patients of those had non-proliferative diabetic retinopathy (NPDR) while the remaining 70 (33.3%) patients had proliferative diabetic retinopathy (PDR) and all patients with PDR had duration of diabetes >15 years (Tables 7 and 8 ). 175 (35%) patients had diabetic nephropathy while 190 (38%) patients had diabetic neuropathy (Tables 9 and 10 ). Most Common risk factor in personal history was tobacco/smoking seen in 210 (42%) patients (Table 11 ).
According to American Diabetic Association (ADA) the cut off point for hypertension in diabetic patient is 130/80mmHg and in this study hypertension was present in 385 (77%) patients (Table 12 ). (Tables 13-15 ). 95/175 (54%) patients with diabetic nephropathy had duration of diabetes >15 years. All diabetic nephropathy patients had HbA1c >7.0% which implies poor glycemic control and all patients with diabetic nephropathy had hypertension (Tables 13-15 ).
80/115 (70%) diabetic patients with no microvascular complications

Discussion
Our study shows a clear correlation of longer duration, poor glycemic control and hypertension with microvascular complications of diabetes. Microvascular complications affect millions of patients with Type II DM. These microvascular complications could lead to visual, renal as well as neurological function impairment including death and also increase the cost to the patient and society. Development of diabetic retinopathy was found to be related to duration, severity of hyperglycemia and presence of hypertension in the UKPDS and most patients with type I DM develop evidence of retinopathy within 20 years of diagnosis [2] [3] [4] . The level of glycaemia seems to be the strongest factor influencing the onset of microalbuminuria [5] [6] [7] [8] [9] . In UKPDS, the incidence of microalbuminuria was 2%/year in patients with type II DM and the 10year prevalence after diagnosis was 25% [10, 11] . Diabetic Neuropathy occurs in 50% of individuals with long standing type I and type II DM. The most rapid deterioration of nerve function occurs soon after type I DM onset. But within 2 to 3 years the progression slows [12] .
In our study 85/210 (40%) patients with diabetic retinopathy had duration of diabetes 10-15 years while 115/210 (55%) had duration >15 years. All 210 patients with diabetic retinopathy had HbA1c > 7.0% which implies poor glycemic control while 190/210 (90%) patients with diabetic retinopathy had hypertension. Diabetic Neuropathy was seen in 20/190 (10.5%) patients with duration of diabetes > 20 years while when duration of diabetes was < 5 years the prevalence of diabetic neuropathy was the least. 185/190 (97%) with diabetic neuropathy had HbA1c >7.0% which again implies poor glycemic control and 175 (92%) patients with diabetic neuropathy had hypertension. 95/175 (54%) patients with diabetic nephropathy had duration of diabetes >15 years. All diabetic nephropathy patients had HbA1c >7.0% which implies poor glycemic control and all patients with diabetic nephropathy had hypertension.
The most important pathogenesis leading to microvascular damage is that hyperglycemia damages capillary endothelial cells in the retina, mesangial cells in the renal glomeruli and Schwan cells of the peripheral [13] . Due to hyperglycemia, there is excess glucose transport in these endothelial cells which leads to damage of these cells. Thus, microvascular complications arises as a result of damage inside these endothelial cells [13, 14] .
Current evidence does support direct relationship between hypertension and poor glycemic control with microvascular complications as also seen in our study. These are termed as independent risk factors for microvascular disease progression [15] . Age, glycated hemoglobin, duration of diabetes, and serum triglycerides are other risk factors as well as smoking, obesity, physical inactivity [16] .
The most common cause of blindness in patient with diabetes is diabetic retinopathy. It is estimated to affect up to 3 million people in the United States alone, by 2050 [17] . The main screening method is annual dilated eye examination to detect diabetic retinopathy [18, 19] . Hyperglycaemia and hypertension are the main risk factors of developing retinopathy in patients with diabetes as also seen with our study [20] . Vascular Diabetic Complications in Southeast Sweden (VISS) study reported similar findings [21] . The VISS study a longitudinal observational study of 451 patients with diabetes who were followed for up to 24 years found that keeping HBA1c below 7.6% was beneficial in preventing retinopathy and persistent microalbuminuria for up to 20 years [21] . Intensive blood pressure control in patients with type 2 diabetes reduced the incidence and progression of diabetic neuropathy over 4-5 years follow up similar to the results in our study.
Diabetic neuropathy most commonly manifests as distal, symmetrical sensorimotor neuropathy [22] . Patient can have negative symptoms in the form of numbness or positive symptoms like tingling, and/or burning pain. It is mainly diagnosed clinically. The tests that can be used include vibration studies and ultrasound. Management should be prompt as delay can have deleterious effects resulting in gangrene and amputations [23, 24] . Management includes good glycemic control as well pharmacological management with tricyclic antidepressants, gabapentin, SSRI (selective serotonin reuptake inhibitors), opioids, antiepileptics, and benzodiazepines [24] [25] [26] [27] . Patients can also be offered certain nonpharmacological management in form of nerve stimulation, electromagnetic field treatment as well as should be advised improvements in sleep quality, and stress reduction [25] .
It is known that diabetic nephropathy occurs in up to 40% of all of patients with diabetes, almost similar to our study in which 35% patients had diabetic nephropathy [28] . Poor glycemic control and hypertension damage the glomeruli. Tight glycemic control is very prudent in primary prevention of micro-albuminuria as seen in various studies [20, 29] . Angiotensin receptor blocker or angiotensin converting enzyme inhibitor is used in the management of diabetic nephropathy along with tight glycemic control, hypertension control, as well as reduced salt intake.
The limitation of our study is that it is retrospective observational study but it does validate the findings of those few studies that are available in the literature, which have shown poor glycemic control and hypertension to be associated with microvascular complications of diabetes.
Conclusion
Microvascular complications tend to occur in those diabetic patients who have long duration of the disease, hypertension and poor glycemic control.
